NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 10, 2024 $0.153 +9.85% $0.147 V 95.98% 1
Jan 10, 2024 $0.161 +15.76% $0.147 V 90.38% 1
JS JS Pro
Jan 5, 2024 $0.170 +6.18% $0.157 X 91.51% 0
Jan 5, 2024 $0.186 +16.03% $0.157 X 81.45% 0
Jan 5, 2024 $0.176 +10.02% $0.157 X 87.59% 0
AlexVel AlexVel Pro
Dec 29, 2023 $0.195 +1.04% $0.170 X 85.02% 0
JS JS Pro
Dec 29, 2023 $0.248 +28.50% $0.170 X 53.77% 0
Dec 29, 2023 $0.176 -8.91% $0.170 V 96.34% 1
Dec 29, 2023 $0.165 -14.25% $0.170 V 97.58% 1
JS JS Pro
Dec 27, 2023 $0.200 +15.54% $0.180 V 88.89% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE